Biomedtech News
Diaccurate Acquires Clinical Stage Sole-in-Class Targeted Cancer Therapy from Merck
Could HIV be cured by tackling ‘bumpy’ CD4 cells? France’s Diaccurate wants to find out
Abivax receives approval for ABX464 phase 1 study in Japanese subjects for subsequent inclusion of Japan into the global phase 3 program in ulcerative colitis
Carmat sells its artificial heart for the first time in Italy
Diaccurate introduces its world-leading scientific advisory board
AFFLUENT MEDICAL announces the success of its initial public offering on the Euronext Paris regulated market
Abivax announces excellent results
TRUFFLE CAPITAL & THE INSTITUT PASTEUR CREATE SPIKIMM TO DEVELOP MONOCLONAL ANTIBODIES AS AN INNOVATIVE TREATMENT FOR COVID-19
Holistick raises $5M to boost preclinical development of PFO closure device